nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—NEK11—thyroid gland—bipolar disorder	0.0302	0.0835	CbGeAlD
Dabrafenib—SLC22A8—urine—bipolar disorder	0.0281	0.0775	CbGeAlD
Dabrafenib—NEK11—cerebellum—bipolar disorder	0.0239	0.0661	CbGeAlD
Dabrafenib—LIMK1—thyroid gland—bipolar disorder	0.0216	0.0598	CbGeAlD
Dabrafenib—NEK11—brain—bipolar disorder	0.0194	0.0537	CbGeAlD
Dabrafenib—SLCO1B1—blood plasma—bipolar disorder	0.0189	0.0521	CbGeAlD
Dabrafenib—LIMK1—cerebellum—bipolar disorder	0.0171	0.0473	CbGeAlD
Dabrafenib—LIMK1—brain—bipolar disorder	0.0139	0.0384	CbGeAlD
Dabrafenib—CYP3A4—urine—bipolar disorder	0.0139	0.0384	CbGeAlD
Dabrafenib—BRAF—thyroid gland—bipolar disorder	0.0134	0.0369	CbGeAlD
Dabrafenib—RAF1—adrenal cortex—bipolar disorder	0.0128	0.0353	CbGeAlD
Dabrafenib—SIK1—thyroid gland—bipolar disorder	0.0112	0.0309	CbGeAlD
Dabrafenib—CYP2C8—blood plasma—bipolar disorder	0.0107	0.0296	CbGeAlD
Dabrafenib—BRAF—cerebellum—bipolar disorder	0.0106	0.0292	CbGeAlD
Dabrafenib—SIK1—nervous system—bipolar disorder	0.00941	0.026	CbGeAlD
Dabrafenib—RAF1—thyroid gland—bipolar disorder	0.00891	0.0246	CbGeAlD
Dabrafenib—SIK1—cerebellum—bipolar disorder	0.00886	0.0245	CbGeAlD
Dabrafenib—BRAF—brain—bipolar disorder	0.0086	0.0237	CbGeAlD
Dabrafenib—RAF1—nervous system—bipolar disorder	0.00749	0.0207	CbGeAlD
Dabrafenib—CYP3A4—blood plasma—bipolar disorder	0.00726	0.02	CbGeAlD
Dabrafenib—SIK1—brain—bipolar disorder	0.0072	0.0199	CbGeAlD
Dabrafenib—RAF1—cerebellum—bipolar disorder	0.00705	0.0195	CbGeAlD
Dabrafenib—RAF1—brain—bipolar disorder	0.00573	0.0158	CbGeAlD
Dabrafenib—SLC22A6—brain—bipolar disorder	0.00556	0.0154	CbGeAlD
Dabrafenib—ABCG2—adrenal cortex—bipolar disorder	0.00529	0.0146	CbGeAlD
Dabrafenib—ABCB1—blood plasma—bipolar disorder	0.00514	0.0142	CbGeAlD
Dabrafenib—SLC22A8—nervous system—bipolar disorder	0.00436	0.012	CbGeAlD
Dabrafenib—ABCG2—thyroid gland—bipolar disorder	0.00369	0.0102	CbGeAlD
Dabrafenib—SLC22A8—brain—bipolar disorder	0.00333	0.0092	CbGeAlD
Dabrafenib—ABCG2—cerebellum—bipolar disorder	0.00292	0.00805	CbGeAlD
Dabrafenib—ABCB1—adrenal cortex—bipolar disorder	0.00261	0.0072	CbGeAlD
Dabrafenib—CYP2C8—brain—bipolar disorder	0.00244	0.00673	CbGeAlD
Dabrafenib—ABCG2—brain—bipolar disorder	0.00237	0.00654	CbGeAlD
Dabrafenib—CYP3A4—nervous system—bipolar disorder	0.00216	0.00596	CbGeAlD
Dabrafenib—ABCB1—thyroid gland—bipolar disorder	0.00182	0.00502	CbGeAlD
Dabrafenib—ABCB1—nervous system—bipolar disorder	0.00153	0.00422	CbGeAlD
Dabrafenib—ABCB1—cerebellum—bipolar disorder	0.00144	0.00397	CbGeAlD
Dabrafenib—ABCB1—brain—bipolar disorder	0.00117	0.00323	CbGeAlD
Dabrafenib—BRAF—Signaling Pathways—DRD5—bipolar disorder	0.000334	0.000524	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—GSK3A—bipolar disorder	0.000334	0.000523	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SLC5A3—bipolar disorder	0.00033	0.000518	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RGS4—bipolar disorder	0.000328	0.000514	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—GSK3A—bipolar disorder	0.00032	0.000502	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—HLA-E—bipolar disorder	0.00032	0.000502	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—IMPA2—bipolar disorder	0.00032	0.000501	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NDUFV2—bipolar disorder	0.00032	0.000501	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.000313	0.000491	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—AKR1C4—bipolar disorder	0.00031	0.000485	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-E—bipolar disorder	0.000307	0.000482	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000307	0.000481	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—ADCY2—bipolar disorder	0.000306	0.00048	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000305	0.000478	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000301	0.000472	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—GSK3B—bipolar disorder	0.0003	0.00047	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—TRPC3—bipolar disorder	0.000297	0.000465	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000297	0.000465	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NDUFV2—bipolar disorder	0.000296	0.000464	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000294	0.000462	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL1B—bipolar disorder	0.000291	0.000456	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—GSK3B—bipolar disorder	0.000288	0.000451	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.000287	0.00045	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—AKR1C4—bipolar disorder	0.000287	0.000449	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—ADM—bipolar disorder	0.000283	0.000444	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CLOCK—bipolar disorder	0.00028	0.00044	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000279	0.000438	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—IMPA2—bipolar disorder	0.000279	0.000437	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000279	0.000437	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NR1D1—bipolar disorder	0.000278	0.000436	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000277	0.000435	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—PDE4B—bipolar disorder	0.000276	0.000433	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—TACR1—bipolar disorder	0.000276	0.000433	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—TSHB—bipolar disorder	0.000276	0.000433	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AKR1C4—bipolar disorder	0.000275	0.000431	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—TPH2—bipolar disorder	0.000273	0.000428	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—TSHB—bipolar disorder	0.000273	0.000428	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CACNB2—bipolar disorder	0.000273	0.000428	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—GSK3B—bipolar disorder	0.000271	0.000425	CbGpPWpGaD
Dabrafenib—BRAF—Disease—SNAP25—bipolar disorder	0.000269	0.000422	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—DPYD—bipolar disorder	0.000269	0.000421	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—S100B—bipolar disorder	0.000267	0.000418	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NCAN—bipolar disorder	0.000266	0.000417	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—SLC5A3—bipolar disorder	0.000261	0.000409	CbGpPWpGaD
Dabrafenib—BRAF—Disease—GSK3A—bipolar disorder	0.000259	0.000407	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000259	0.000405	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NR1D1—bipolar disorder	0.000257	0.000404	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000257	0.000403	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TRPC3—bipolar disorder	0.000253	0.000397	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DGKH—bipolar disorder	0.000253	0.000396	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CACNA1C—bipolar disorder	0.00025	0.000392	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NCAN—bipolar disorder	0.000246	0.000386	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000244	0.000383	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PIK3C2A—bipolar disorder	0.000244	0.000382	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000243	0.000381	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ADM—bipolar disorder	0.000242	0.000379	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—POMC—bipolar disorder	0.000242	0.000379	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—SLC5A3—bipolar disorder	0.000241	0.000378	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.00024	0.000377	CbGpPWpGaD
Dabrafenib—BRAF—Disease—ADCY2—bipolar disorder	0.000238	0.000373	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TCF7L2—bipolar disorder	0.000237	0.000372	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PDE4B—bipolar disorder	0.000236	0.000369	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TSHB—bipolar disorder	0.000236	0.000369	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TACR1—bipolar disorder	0.000236	0.000369	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—NRG1—bipolar disorder	0.000235	0.000369	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DRD5—bipolar disorder	0.000231	0.000363	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR1A—bipolar disorder	0.000228	0.000358	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RGS4—bipolar disorder	0.000227	0.000356	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—NRG1—bipolar disorder	0.000226	0.000354	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—TAC1—bipolar disorder	0.000225	0.000353	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL1B—bipolar disorder	0.000224	0.000352	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR2C—bipolar disorder	0.000221	0.000346	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—DRD1—bipolar disorder	0.000221	0.000346	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—SNAP25—bipolar disorder	0.000218	0.000342	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—IMPA1—bipolar disorder	0.000216	0.000339	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—DRD3—bipolar disorder	0.000214	0.000335	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL1B—bipolar disorder	0.000212	0.000332	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000211	0.000331	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000211	0.000331	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—DRD4—bipolar disorder	0.000207	0.000325	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—COMT—bipolar disorder	0.000201	0.000315	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—MAOA—bipolar disorder	0.000199	0.000312	CbGpPWpGaD
Dabrafenib—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	0.000198	0.00031	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—ADCY2—bipolar disorder	0.000195	0.000306	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR1A—bipolar disorder	0.000195	0.000306	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—GSK3A—bipolar disorder	0.000194	0.000305	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—GSK3B—bipolar disorder	0.000193	0.000303	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ADCY2—bipolar disorder	0.000193	0.000303	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—DRD2—bipolar disorder	0.000193	0.000303	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TAC1—bipolar disorder	0.000192	0.000301	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—INS—bipolar disorder	0.000191	0.000299	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CLOCK—bipolar disorder	0.000188	0.000295	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR2C—bipolar disorder	0.000188	0.000295	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—DRD1—bipolar disorder	0.000188	0.000295	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—IMPA1—bipolar disorder	0.000188	0.000295	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-E—bipolar disorder	0.000186	0.000292	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SNAP25—bipolar disorder	0.000186	0.000292	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NDUFV2—bipolar disorder	0.000184	0.000288	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—TPH2—bipolar disorder	0.000184	0.000288	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—TSHB—bipolar disorder	0.000184	0.000288	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CACNB2—bipolar disorder	0.000184	0.000288	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NTRK2—bipolar disorder	0.000183	0.000287	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NRG1—bipolar disorder	0.000183	0.000287	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—DRD3—bipolar disorder	0.000182	0.000286	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GSK3A—bipolar disorder	0.000182	0.000285	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—DPYD—bipolar disorder	0.000181	0.000283	CbGpPWpGaD
Dabrafenib—RAF1—Disease—GSK3A—bipolar disorder	0.000179	0.000281	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ADCY2—bipolar disorder	0.000178	0.00028	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—AKR1C4—bipolar disorder	0.000178	0.000279	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—DRD4—bipolar disorder	0.000177	0.000278	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TRPC3—bipolar disorder	0.000175	0.000275	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CLOCK—bipolar disorder	0.000174	0.000273	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—IMPA2—bipolar disorder	0.000172	0.000269	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—GSK3B—bipolar disorder	0.000171	0.000268	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—TPH2—bipolar disorder	0.00017	0.000267	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—TSHB—bipolar disorder	0.00017	0.000267	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CACNB2—bipolar disorder	0.00017	0.000267	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CACNA1C—bipolar disorder	0.000168	0.000263	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—DPYD—bipolar disorder	0.000167	0.000262	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ADM—bipolar disorder	0.000167	0.000262	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ADCY2—bipolar disorder	0.000167	0.000261	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TCF7L2—bipolar disorder	0.000166	0.00026	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—COMT—bipolar disorder	0.000166	0.00026	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—DRD2—bipolar disorder	0.000165	0.000259	CbGpPWpGaD
Dabrafenib—BRAF—Disease—MTHFR—bipolar disorder	0.000165	0.000258	CbGpPWpGaD
Dabrafenib—RAF1—Disease—ADCY2—bipolar disorder	0.000165	0.000258	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—MAOA—bipolar disorder	0.000164	0.000258	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—GSK3B—bipolar disorder	0.000164	0.000257	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TCF7L2—bipolar disorder	0.000164	0.000257	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PIK3C2A—bipolar disorder	0.000164	0.000257	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PDE4B—bipolar disorder	0.000163	0.000255	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TSHB—bipolar disorder	0.000163	0.000255	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TACR1—bipolar disorder	0.000163	0.000255	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000161	0.000253	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NDUFV2—bipolar disorder	0.00016	0.000251	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NR1D1—bipolar disorder	0.00016	0.000251	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CACNA1C—bipolar disorder	0.000155	0.000244	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—S100B—bipolar disorder	0.000155	0.000244	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—AKR1C4—bipolar disorder	0.000155	0.000243	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NCAN—bipolar disorder	0.000153	0.00024	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PIK3C2A—bipolar disorder	0.000152	0.000238	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SLC5A3—bipolar disorder	0.00015	0.000235	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NTRK1—bipolar disorder	0.000149	0.000234	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—SNAP25—bipolar disorder	0.000147	0.00023	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—S100B—bipolar disorder	0.000145	0.000228	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.00014	0.000219	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NR1D1—bipolar disorder	0.000139	0.000218	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000139	0.000218	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NRG1—bipolar disorder	0.000137	0.000215	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—SNAP25—bipolar disorder	0.000136	0.000213	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR2A—bipolar disorder	0.000135	0.000212	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR1A—bipolar disorder	0.000135	0.000211	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—MTHFR—bipolar disorder	0.000134	0.00021	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NCAN—bipolar disorder	0.000133	0.000209	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TAC1—bipolar disorder	0.000133	0.000208	CbGpPWpGaD
Dabrafenib—BRAF—Disease—GSK3B—bipolar disorder	0.000133	0.000208	CbGpPWpGaD
Dabrafenib—BRAF—Disease—INS—bipolar disorder	0.000131	0.000205	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SLC5A3—bipolar disorder	0.00013	0.000205	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR2C—bipolar disorder	0.00013	0.000204	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DRD1—bipolar disorder	0.00013	0.000204	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ADCY2—bipolar disorder	0.00013	0.000204	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—POMC—bipolar disorder	0.00013	0.000203	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NRG1—bipolar disorder	0.000128	0.000201	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NTRK2—bipolar disorder	0.000127	0.000199	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NRG1—bipolar disorder	0.000127	0.000198	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DRD3—bipolar disorder	0.000126	0.000198	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GSK3A—bipolar disorder	0.000126	0.000197	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DRD4—bipolar disorder	0.000122	0.000192	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ADCY2—bipolar disorder	0.00012	0.000189	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—IMPA1—bipolar disorder	0.000116	0.000182	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR2A—bipolar disorder	0.000116	0.000181	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ADCY2—bipolar disorder	0.000115	0.000181	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TCF7L2—bipolar disorder	0.000115	0.00018	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DRD2—bipolar disorder	0.000114	0.000179	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MTHFR—bipolar disorder	0.000114	0.000179	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—COMT—bipolar disorder	0.000111	0.000174	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—MAOA—bipolar disorder	0.00011	0.000173	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CLOCK—bipolar disorder	0.000108	0.00017	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—POMC—bipolar disorder	0.000108	0.000169	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—POMC—bipolar disorder	0.000107	0.000168	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—INS—bipolar disorder	0.000106	0.000167	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—TSHB—bipolar disorder	0.000105	0.000165	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CACNB2—bipolar disorder	0.000105	0.000165	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—TPH2—bipolar disorder	0.000105	0.000165	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—DPYD—bipolar disorder	0.000104	0.000163	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NTRK1—bipolar disorder	0.000103	0.000162	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—COMT—bipolar disorder	0.000103	0.000161	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—MAOA—bipolar disorder	0.000102	0.00016	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—S100B—bipolar disorder	0.0001	0.000157	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—GSK3B—bipolar disorder	9.95e-05	0.000156	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	9.86e-05	0.000155	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CACNA1C—bipolar disorder	9.65e-05	0.000151	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	9.55e-05	0.00015	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CLOCK—bipolar disorder	9.43e-05	0.000148	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PIK3C2A—bipolar disorder	9.4e-05	0.000147	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GSK3B—bipolar disorder	9.3e-05	0.000146	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	9.28e-05	0.000145	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—POMC—bipolar disorder	9.23e-05	0.000145	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—TSHB—bipolar disorder	9.19e-05	0.000144	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—TPH2—bipolar disorder	9.19e-05	0.000144	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CACNB2—bipolar disorder	9.19e-05	0.000144	CbGpPWpGaD
Dabrafenib—RAF1—Disease—GSK3B—bipolar disorder	9.19e-05	0.000144	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—INS—bipolar disorder	9.17e-05	0.000144	CbGpPWpGaD
Dabrafenib—RAF1—Disease—INS—bipolar disorder	9.06e-05	0.000142	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—DPYD—bipolar disorder	9.04e-05	0.000142	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—MTHFR—bipolar disorder	8.99e-05	0.000141	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NRG1—bipolar disorder	8.86e-05	0.000139	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NR1D1—bipolar disorder	8.58e-05	0.000134	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SNAP25—bipolar disorder	8.43e-05	0.000132	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CACNA1C—bipolar disorder	8.41e-05	0.000132	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—MTHFR—bipolar disorder	8.33e-05	0.000131	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NCAN—bipolar disorder	8.2e-05	0.000129	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	8.19e-05	0.000128	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	8.04e-05	0.000126	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR2A—bipolar disorder	7.99e-05	0.000125	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADCY2—bipolar disorder	7.46e-05	0.000117	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SNAP25—bipolar disorder	7.35e-05	0.000115	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1B—bipolar disorder	7.33e-05	0.000115	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—POMC—bipolar disorder	7.19e-05	0.000113	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—INS—bipolar disorder	7.15e-05	0.000112	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—POMC—bipolar disorder	6.66e-05	0.000104	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—INS—bipolar disorder	6.62e-05	0.000104	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADCY2—bipolar disorder	6.5e-05	0.000102	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GSK3B—bipolar disorder	6.43e-05	0.000101	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—COMT—bipolar disorder	6.39e-05	0.0001	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—POMC—bipolar disorder	6.38e-05	0.0001	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—INS—bipolar disorder	6.35e-05	9.95e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MAOA—bipolar disorder	6.35e-05	9.95e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CLOCK—bipolar disorder	5.81e-05	9.11e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—TSHB—bipolar disorder	5.66e-05	8.88e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—TPH2—bipolar disorder	5.66e-05	8.88e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CACNB2—bipolar disorder	5.66e-05	8.88e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—DPYD—bipolar disorder	5.57e-05	8.73e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—COMT—bipolar disorder	5.57e-05	8.73e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MAOA—bipolar disorder	5.53e-05	8.67e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	5.18e-05	8.12e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MTHFR—bipolar disorder	5.17e-05	8.1e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	5.05e-05	7.91e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SNAP25—bipolar disorder	4.53e-05	7.1e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MTHFR—bipolar disorder	4.5e-05	7.06e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—POMC—bipolar disorder	4.13e-05	6.48e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—INS—bipolar disorder	4.11e-05	6.44e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADCY2—bipolar disorder	4.01e-05	6.28e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—POMC—bipolar disorder	3.6e-05	5.64e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—INS—bipolar disorder	3.58e-05	5.61e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—COMT—bipolar disorder	3.43e-05	5.38e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MAOA—bipolar disorder	3.41e-05	5.34e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MTHFR—bipolar disorder	2.77e-05	4.35e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—POMC—bipolar disorder	2.22e-05	3.48e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—INS—bipolar disorder	2.21e-05	3.46e-05	CbGpPWpGaD
